Magnetic Nanoparticles Are Launched by Creative Diagnostics for Research Community

New magnetic nanoparticles have been launched by Creative Diagnostics to enable bioresearch.

Recently, a new range of magnetic nanoparticles have been launched by Creative Diagnostics to enable reliable and biologically relevant research on hyperthermia and photodynamic therapy, immunoassay, bioseparation, medical imaging and diagnosis, as well as drug delivery and cancer therapy. As a global leading manufacturer of magnetic particles and related products for immunoassay development, Creative Diagnostics now offers bio-researchers more choices on magnetic nanoparticles, allowing them to better pursue their research goals.   

Generally speaking, nanoparticles refer to particles in the size range of 0.1 to 100 nm, where particles show completely novel physicochemical properties from their bulk counterpart. The promise of nanoparticles for diagnostic and therapeutic applications has been widely explored. For diagnostic applications, the specificity and sensitivity of imaging can be greatly improved by using nanoparticles as contrast enhancement agents. As therapeutic agent, nanoparticles enable targeted and controlled drug delivery.

Creative Diagnostics now provides highly uniform magnetic nanoparticles for laboratory use in biology and medicine, which include a wide range of related products such as colloidal gold nanoparticles, silver nanoparticles, silica nanoparticles, titania nanoparticles, inorganic fluorescent nanoparticles (quantum dots and upconversion nanocrystals), as well as biodegradable polymer nanoparticles. They are manufactured with different shapes and sizes, and the particle surface can be coated, functionalized or conjugated with biomolecules.

“Based on rich experience in particles manufacturing, Creative Diagnostics now is able to supply the most comprehensive list of nanoparticles products with different sizes and various surface properties (coated, functionalized or conjugated with biomolecules) to meet researchers’ specific requirements in both research and industrial development.” said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.

“These newly launched nanoparticles are designed to optimize the related scientific research and are the latest additions to Creative Diagnostics’ product portfolio. We optimized the related nanoparticles products to ensure its highest quality. For researchers who are focusing on drug delivery and cancer therapy, this should save time and help them advance research.” said Dr. Randy S. Vaughn, senior researcher at Creative Diagnostics.

For more detailed information on magnetic nanoparticles, please contact Creative Diagnostics directly at 1-631-619-7922 or email to 

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer of magnetic particles and related products for immunoassay development. It provides a comprehensive list of immunomagnetic bead products conjugated with different coating materials and functional groups in multiple sizes to meet your need for research and industrial prospect development.

Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: NY
Country: United States